You are looking for

As a medtech lawyer, my focus naturally gravitates to assessing “downstream” relationships and risk; that is, analysis of the legal arrangements between manufacturers, distribution agents, and health care providers that together bring medical technologies to the patient’s bedside. These relationships can be complex, as are the legal issues they raise. But ensuring ethical standards in these relationships […]

Colorectal cancers are the third most common type of cancer and the second most common cause of death in Europe. The month of March has been chosen as “Colorectal Cancer Awareness Month”, to raise awareness about this disease, as detecting it as early as possible can save many lives. As a surgical oncologist, I can […]

The argument has raged for some time and shows no sign of abating any time soon: screening for diseases, yes or no? Take the case of prostate cancer screening: Richard Ablin – the author of “The Great Prostate Hoax”, and the man who claims to be the first to have identified PSA (a protein created […]

Most Europeans born today will live into their eighties but behind that impressive statistic lie inequalities and ill-health. It’s time we focused on adding life to years instead of years to life. In 1990, life expectancy at birth was 74.1 years in Europe. Today, it’s 80.9. This is a remarkable achievement, by any measure. However, […]

A 2015 report from The Lancet Global Surgery Commission found that nearly one-third of the global burden of disease can be treated surgically and that 5 billion people lack access to safe and affordable surgical care.  At Johnson & Johnson, we are looking to improve the standard of care and treatment, accelerating our pace of […]

eHealth technologies are pulling together personal information from diverse sources to ensure a more personalised, informed healthcare service – it’s what patients expect Precision medicine is the use of all available information about a patient to produce the most informed care plan possible. This is often associated with using genetic or other “-omics” information to […]

Artificial intelligence technology can help to meet rising demand for early detection of melanoma. Skin cancer and melanoma (the most severe type of skin cancer) are becoming a social health issue. The incidence has been rising. Currently, between 2 and 3 million non-melanoma skin cancers and 132,000 melanoma skin cancers occur globally each year.  Experts […]

Every family has a cancer story. If you have not had direct personal experience of cancer, the chances are that you know a loved one, a friend or a colleague who has. More than three million people in Europe are diagnosed with cancer every year, and 1.7 million cancer deaths are recorded annually. The death […]

Almost one-third of California women with ovarian cancer survive at least 10 years after diagnosis. The findings upend the notion that women diagnosed with cancer of the ovary always face a poor chance of survival. In fact, while the study confirmed earlier findings on characteristics associated with ovarian cancer survival—younger age, earlier stage, and lower […]